issue

Jun 2, 2025

Volume 21 Number 11

This issue of EuroIntervention includes an expert consensus of the European Left Atrial Appendage Closure Club presenting their ELAAC classification system for left atrial appendage closure. In original research: an article on how measuring pericoronary adipose tissue attenuation can predict outcomes after PCI, 5-year results of the SORT OUT VIII and SORT OUT IX trials looking at biolimus vs sirolimus drug-coated and drug-eluting stents and comparing a biodegradable-polymer vs a durable-polymer drug-eluting stent for use in left main PCI. The research correspondence discusses 5-year results from the IDEAL-LM trial which compared a biodegradable-polymer vs a durable-polymer drug-eluting stent for use in left main PCI. The trial design covers the design and rationale of the PRAGUE-26 trial for catheter-directed thrombolysis in pulmonary embolism patients. The Anchor the Mother to Advance the Child (AMAC) technique for complex PCI is covered in a flashlight, and then, there is news from the EAPCI; and more...

Expert Consensus

A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
Nielsen-Kudsk J, Aminian A, Backer O, Iriart X, Berti S, Galea R, Freixa X, Räber L, Cruz-González I, Wunderlich N, Garot P
10.4244/EIJ-D-24-00954

Original Research

Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention
Naniwa S, Kawamori H, Toba T, Hiromasa T, Sugizaki Y, Sasaki S, Fujii H, Hamana T, Osumi Y, Yamamoto T, Iwane S, Sakamoto Y, Matsuhama K, Fukuishi Y, Tsunamoto H, Higuchi K, Okamoto H, Iwasaki M, Takaya T, Yamada S, Hirata K, Otake H
10.4244/EIJ-D-24-00971

Editorial comment

Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent
Jensen L, Jakobsen L, Eftekhari A, Ellert-Gregersen J, Støttrup N, Engstrøm T, Kahlert J, Freeman P, Veien K, Jensen R, Lassen J, Junker A, Christiansen E
10.4244/EIJ-D-24-00586

Editorial comment

Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial
Støttrup N, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, Thim T, Jakobsen L, Jensen R, Eftekhari A, Freeman P, Jensen S, Veien K, Jensen L, Maeng M, for Randomized Trials with Clinical Outcome (SORT OUT) ftSO
10.4244/EIJ-D-24-00763

Research Correspondence

Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial
Griffioen A, van Geuns R, McEntegart M, Merkulov E, Krestyaninov O, Kretov E, Lesiak M, O’Kane P, Hanratty C, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd K
10.4244/EIJ-D-24-00918

Trial Design

Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism
Kroupa J, Radvan M, Mrozek J, Sluka M, Jirous S, Hlinomaz O, Pliva M, Pudil J, Voberkova H, Kozel M, Poloczek M, Kamenik M, Brabec M, Lichnerova E, Hutyra M, Bernat I, Novak M, Tousek P, Kocka V
10.4244/EIJ-D-24-01085
open access

Flashlight

AMAC: Anchor the Mother to Advance the Child – a technique for complex PCI
Cocco N, Leibundgut G, Spanò A, Weilennmann D, Mashayekhi K
10.4244/EIJ-D-24-01058

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved